Paola Zuccalà

Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia

Maria Antonella Zingaropoli, Parni Nijhawan, Anna Carraro et al. · Frontiers in Immunology · 2021 · 225 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II)

Ernesto Maddaloni, Luca D’Onofrio, Francesco Alessandri et al. · Cardiovascular Diabetology · 2020 · 114 citations · Full text

Medicine, Internal Medicine, Critical Care Cardiology +11

Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

Maria Carmela Piccirillo, Paolo A. Ascierto, Carlo Salvarani et al. · Journal of Translational Medicine · 2020 · 112 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon

Claudia Mascia, Serena Vita, Paola Zuccalà et al. · PLoS ONE · 2017 · 49 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Liver Fibrosis in HCV Monoinfected and HIV/HCV Coinfected Patients: Dysregulation of Matrix Metalloproteinases (MMPs) and Their Tissue Inhibitors TIMPs and Effect of HCV Protease Inhibitors

Tiziana Latronico, Claudia Mascia, Ilaria Pati et al. · International Journal of Molecular Sciences · 2016 · 48 citations · Full text

Veterinary Medicine, Infectious Diseases, Pathobiology +17